The cellular autophagy pathway modulates human T-cell leukemia virus type 1 replication

Journal of Virology

Volumn 87, Issue 3, 2013, Pages 1699-1707

  Tang, Sai Wen ^a   Chen, Chia Yen ^a   Klase, Zachary ^a   Zane, Linda ^a   Jeang, Kuan Teh ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BAFILOMYCIN; BAFILOMYCIN A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TAX PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CELL AGGREGATION; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS INFECTION; LYSOSOME; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN STABILITY; REGULATORY MECHANISM; VIRUS REPLICATION;

AUTOPHAGY; CELL LINE; CYTOPLASM; GENE PRODUCTS, TAX; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PHAGOSOMES; VIRUS REPLICATION;

EID: 84873038774     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02147-12     Document Type: Article

References (81)

1. Gallo RC. 2005. The discovery of the first human retrovirus: HTLV-1 and HTLV-2. Retrovirology 2:17. doi:10.1186/1742-4690-2-17.
2. Takatsuki K. 2005. Discovery of adult T-cell leukemia. Retrovirology 2:16. doi:10.1186/1742-4690-2-16.
3. Martin F, Bangham CR, Ciminale V, Lairmore MD, Murphy EL, Switzer WM, Mahieux R. 2011. Conference highlights of the 15th International Conference on Human Retrovirology: HTLV and related retroviruses, 4-8 June 2011, Leuven, Gembloux, Belgium. Retrovirology 8:86. doi:10.1186/1742-4690-8-86.
4. Proietti FA, Carneiro-Proietti AB, Catalan-Soares BC, Murphy EL. 2005. Global epidemiology of HTLV-I infection and associated diseases. Oncogene 24:6058-6068.
5. Ghez D, Lepelletier Y, Jones KS, Pique C, Hermine O. 2010. Current concepts regarding the HTLV-1 receptor complex. Retrovirology 7:99. doi:10.1186/1742-4690-7-99.
6. Yasunaga J, Matsuoka M. 2011. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int. J. Hematol. 94:435-442.
7. Gallo RC. 2011. Research and discovery of the first human cancer virus, HTLV-1. Best Pract. Res. Clin. Haematol. 24:559-565.
8. Yamaguchi K. 1994. Human T-lymphotropic virus type I in Japan. Lancet 343:213-216.
9. Yoshida M. 2005. Discovery of HTLV-1, the first human retrovirus, its unique regulatory mechanisms, and insights into pathogenesis. Oncogene 24:5931-5937.
10. Gessain A. 1996. Virological aspects of tropical spastic paraparesis/ HTLV-I associated myelopathy and HTLV-I infection. J. Neurovirol. 2:299-306.
11. Osame M. 2002. Pathological mechanisms of human T-cell lymphotropic virus type I-associated myelopathy (HAM/TSP). J. Neurovirol. 8:359-364.
12. Giam CZ, Jeang KT. 2007. HTLV-1 Tax and adult T-cell leukemia. Front. Biosci. 12:1496-1507.
13. Higuchi M, Fujii M. 2009. Distinct functions of HTLV-1 Tax1 from HTLV-2 Tax2 contribute key roles to viral pathogenesis. Retrovirology 6:117. doi:10.1186/1742-4690-6-117.
14. Robek MD, Ratner L. 1999. Immortalization of CD4(+) and CD8(+) T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 73:4856-4865.
15. Rosin O, Koch C, Schmitt I, Semmes OJ, Jeang KT, Grassmann R. 1998. A human T-cell leukemia virus Tax variant incapable of activating NFkappaB retains its immortalizing potential for primary T-lymphocytes. J. Biol. Chem. 273:6698-6703.
16. Adya N, Zhao LJ, Huang W, Boros I, Giam CZ. 1994. Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc. Natl. Acad. Sci. U. S. A. 91:5642-5646.
17. Green PL, Chen IS. 1990. Regulation of human T cell leukemia virus expression. FASEB J. 4:169-175.
18. Jeang KT, Boros I, Brady J, Radonovich M, Khoury G. 1988. Characterization of cellular factors that interact with the human T-cell leukemia virus type I p40x-responsive 21-base-pair sequence. J. Virol. 62:4499-4509.
19. Kim YM, Geiger TR, Egan DI, Sharma N, Nyborg JK. 2010. The HTLV-1 tax protein cooperates with phosphorylated CREB, TORC2 and p300 to activate CRE-dependent cyclin D1 transcription. Oncogene 29: 2142-2152.
20. Kwok RP, Laurance ME, Lundblad JR, Goldman PS, Shih H, Connor LM, Marriott SJ, Goodman RH. 1996. Control of CAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature 380:642-646.
21. Siu YT, Chin KT, Siu KL, Yee Wai Choy E, Jeang KT, Jin DY. 2006. TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J. Virol. 80: 7052-7059.
22. Bonnet A, Randrianarison-Huetz V, Nzounza P, Nedelec M, Chazal M, Waast L, Pene S, Bazarbachi A, Mahieux R, Benit L, Pique C. 2012. Low nuclear body formation and tax SUMOylation do not prevent NF-kappaB promoter activation. Retrovirology 9:77. doi:10.1186/1742-4690-9-77.
23. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. 2008. The HTLV-1 Tax interactome. Retrovirology 5:76. doi:10.1186 /1742-4690-5-76.
24. Ng PW, Iha H, Iwanaga Y, Bittner M, Chen Y, Jiang Y, Gooden G, Trent JM, Meltzer P, Jeang KT, Zeichner SL. 2001. Genome-wide expression changes induced by HTLV-1 Tax: evidence for MLK-3 mixed lineage kinase involvement in Tax-mediated NF-kappaB activation. Oncogene 20:4484-4496.
25. Peloponese JM, Yeung ML, Jeang KT. 2006. Modulation of nuclear factor-kappaB by human T cell leukemia virus type 1 Tax protein: implications for oncogenesis and inflammation. Immunol. Res. 34:1-12.
26. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC. 2012. Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology 9:26. doi:10.1186/1742-4690-9-26.
27. Xiao G. 2012. NF-kappaB activation: Tax sumoylation is out, but what about Tax ubiquitination. Retrovirology 9:78. doi:10.1186/1742-4690-9-78.
28. Glick D, Barth S, Macleod KF. 2010. Autophagy: cellular and molecular mechanisms. J. Pathol. 221:3-12.
29. Xie Z, Klionsky DJ. 2007. Autophagosome formation: core machinery and adaptations. Nat. Cell Biol. 9:1102-1109.
30. Klionsky DJ, Abeliovich H, Agostinis P, Agrawal DK, Aliev G, Askew DS, Baba M, Baehrecke EH, Bahr BA, Ballabio A, Bamber BA, Bassham DC, Bergamini E, Bi X, Biard-Piechaczyk M, Blum JS, Bredesen DE, Brodsky JL, Brumell JH, Brunk UT, Bursch W, Camougrand N, Cebollero E, Cecconi F, Chen Y, Chin LS, Choi A, Chu CT, Chung J, Clarke PG, Clark RS, Clarke SG, Clave C, Cleveland JL, Codogno P, Colombo MI, Coto-Montes A, Cregg JM, Cuervo AM, Debnath J, Demarchi F, Dennis PB, Dennis PA, Deretic V, Devenish RJ, Di Sano F, Dice JF, Difiglia M, Dinesh-Kumar S, Distelhorst CW, Djavaheri-Mergny M, Dorsey FC, Droge W, Dron M, Dunn WA, Jr, Duszenko M, Eissa NT, Elazar Z, Esclatine A, Eskelinen EL, Fesus L, Finley KD, Fuentes JM, Fueyo J, Fujisaki K, Galliot B, Gao FB, Gewirtz DA, Gibson SB, Gohla A, Goldberg AL, Gonzalez R, Gonzalez-Estevez C, Gorski S, Gottlieb RA, Haussinger D, He YW, Heidenreich K, Hill JA, Hoyer-Hansen M, Hu X, Huang WP, Iwasaki A, Jaattela M, Jackson WT, Jiang X, Jin S, Johansen T, Jung JU, Kadowaki M, Kang C, Kelekar A, Kessel DH, Kiel JA, Kim HP, Kimchi A, Kinsella TJ, Kiselyov K, Kitamoto K, Knecht E, et al. 2008. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4151-175.
31. Knaevelsrud H, Simonsen A. 2012. Lipids in autophagy: constituents, signaling molecules and cargo with relevance to disease. Biochim. Biophys. Acta 1821:1133-1145.
32. Levine B, Kroemer G. 2008. Autophagy in the pathogenesis of disease. Cell 132:27-42.
33. Dreux M, Chisari FV. 2010. Viruses and the autophagy machinery. Cell Cycle 9:1295-1307.
34. Tang SW, Ducroux A, Jeang KT, Neuveut C. 2012. Impact of cellular autophagy on viruses: insights from hepatitis B virus and human retroviruses. J. Biomed. Sci. 19:92. doi:10.1186/1423-0127-19-92.
35. Sir D, Ou JH. 2010. Autophagy in viral replication and pathogenesis. Mol. Cells 29:1-7.
36. Cavignac, Y, Esclatine A. 2010. Herpesviruses and autophagy: catch me if you can. Viruses 2:314-333.
37. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, Alexander D, Leib D, Norbury C, Lippe R, Desjardins M. 2009. Autophagy enhances the presentation of endogenous viral antigens onMHC class I molecules during HSV-1 infection. Nat. Immunol. 10:480-487.
38. Gannage M, Dormann D, Albrecht R, Dengjel J, Torossi T, Ramer PC, Lee M, Strowig T, Arrey F, Conenello G, Pypaert M, Andersen J, Garcia-Sastre A, Munz C. 2009. Matrix protein 2 of influenza A virus blocks autophagosome fusion with lysosomes. Cell Host Microbe 6:367-380.
39. + T cells and macrophages. Front. Immunol. 3:97. doi:10.3389/fimmu.2012.00097.
40. Espert L, Varbanov M, Robert-Hebmann V, Sagnier S, Robbins I, Sanchez F, Lafont V, Biard-Piechaczyk M. 2009. Differential role of autophagy in CD4 T cells and macrophages during X4 and R5 HIV-1 infection. PLoS One 4:e5787. doi:10.1371/journal.pone.0005787.
41. Kyei GB, Dinkins C, Davis AS, Roberts E, Singh SB, Dong C, Wu L, Kominami E, Ueno T, Yamamoto A, Federico M, Panganiban A, Vergne I, Deretic V. 2009. Autophagy pathway intersects with HIV-1 biosynthesis and regulates viral yields in macrophages. J. Cell Biol. 186: 255-268.
42. + T cells. Cell. Signal. 24:1414-1419.
43. Zhou D, Spector SA. 2008. Human immunodeficiency virus type-1 infection inhibits autophagy. AIDS 22:695-699.
44. Li JC, Au KY, Fang JW, Yim HC, Chow KH, Ho PL, Lau AS. 2011. HIV-1 trans-activator protein dysregulates IFN-gamma signaling and contributes to the suppression of autophagy induction. AIDS 25:15-25.
45. Van Grol J, Subauste C, Andrade RM, Fujinaga K, Nelson J, Subauste CS. 2010. HIV-1 inhibits autophagy in bystander macrophage/monocytic cells through Src-Akt and STAT3. PLoS One 5:e11733. doi:10.1371 /journal.pone.0011733.
46. Campbell GR, Spector SA. 2011. Hormonally active vitamin D3 (1alpha, 25-dihydroxycholecalciferol) triggers autophagy in human macrophages that inhibits HIV-1 infection. J. Biol. Chem. 286:18890-18902.
47. Campbell GR, Spector SA. 2012. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog. 8:e1002689. doi:10.1371/journal.ppat.1002689.
48. Cheng H, Ren T, Sun SC. 2012. New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. Protein Cell 3:581-589.
49. + memory T lymphocytes by oncogenic activation and dysregulation of autophagy. J. Biol. Chem. 287:34683-34693.
50. Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Overvatn A, Bjorkoy G, Johansen T. 2007. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282:24131-24145.
51. Zhao TM, Robinson MA, Bowers FS, Kindt TJ. 1995. Characterization of an infectious molecular clone of human T-cell leukemia virus type I. J. Virol. 69:2024-2030.
52. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, Kominami E, Ohsumi Y, Yoshimori T. 2000. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19:5720-5728.
53. Kimura S, Noda T, Yoshimori T. 2007. Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescenttagged LC3. Autophagy 3:452-460.
54. Smith MR, Greene WC. 1990. Identification of HTLV-I tax transactivator mutants exhibiting novel transcriptional phenotypes. Genes Dev. 4:1875-1885.
55. Zane L, Sibon D, Jeannin L, Zandecki M, Delfau-Larue MH, Gessain A, Gout O, Pinatel C, Lancon A, Mortreux F, Wattel E. 2010. Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo. Retrovirology 7:17. doi:10.1186/1742-4690-7-17.
56. Chen CY, Chi YH, Mutalif RA, Starost MF, Myers TG, Anderson SA, Stewart CL, Jeang KT. 2012. Accumulation of the inner nuclear envelope protein Sun1 is pathogenic in progeric and dystrophic laminopathies. Cell 149:565-577.
57. Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y. 1998. Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct. Funct. 23:33-42.
58. Chen PM, Gombart ZJ, Chen JW. 2011. Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci. 1:10. doi:10.1186/2045-3701-1-10.
59. Seglen PO, Grinde B, Solheim AE. 1979. Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin. Eur. J. Biochem. 95:215-225.
60. Tanaka Y, Guhde G, Suter A, Eskelinen EL, Hartmann D, Lullmann-Rauch R, Janssen PM, Blanz J, von Figura K, Saftig P. 2000. Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice. Nature 406:902-906.
61. Boxus M, Twizere JC, Legros S, Kettmann R, Willems L. 2012. Interaction of HTLV-1 Tax with minichromosome maintenance proteins accelerates the replication timing program. Blood 119:151-160.
62. Boxus M, Willems L. 2012. How the DNA damage response determines the fate of HTLV-1 Tax-expressing cells. Retrovirology 9:2. doi:10.1186 /1742-4690-9-2.
63. Peloponese JM, Jr, Haller K, Miyazato A, Jeang KT. 2005. Abnormal centrosome amplification in cells through the targeting of Ran-binding protein-1 by the human T cell leukemia virus type-1 Tax oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 102:18974-18979.
64. Belgnaoui SM, Fryrear KA, Nyalwidhe JO, Guo X, Semmes OJ. 2010. The viral oncoprotein tax sequesters DNA damage response factors by tethering MDC1 to chromatin. J. Biol. Chem. 285:32897-32905.
65. Gatza ML, Watt JC, Marriott SJ. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene 22:5141-5149.
66. Majone F, Jeang KT. 2000. Clastogenic effect of the human T-cell leukemia virus type I Tax oncoprotein correlates with unstabilizedDNAbreaks. J. Biol. Chem. 275:32906-32910.
67. Majone F, Jeang KT. 2012. Unstabilized DNA breaks in HTLV-1 Tax expressing cells correlate with functional targeting of Ku80, not PKcs, XRCC4, or H2AX. Cell Biosci. 2:15. doi:10.1186/2045-3701-2-15.
68. Ramadan E, Ward M, Guo X, Durkin SS, Sawyer A, Vilela M, Osgood C, Pothen A, Semmes OJ. 2008. Physical and in silico approaches identify DNA-PK in a Tax DNA-damage response interactome. Retrovirology 5:92. doi:10.1186/1742-4690-5-92.
69. Matsuoka M, Jeang KT. 2011. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 30:1379-1389.
70. Jackson WT, Giddings TH, Jr, Taylor MP, Mulinyawe S, Rabinovitch M, Kopito RR, Kirkegaard K. 2005. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3:e156. doi:10.1371/journal .pbio.0030156.
71. Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y, Giam CZ. 1998. An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP/p300. Mol. Cell. Biol. 18:5052-5061.
72. Harhaj EW, Harhaj NS. 2005. Mechanisms of persistent NF-kappaB activation by HTLV-I tax. IUBMB Life 57:83-91.
73. Qu Z, Xiao G. 2011. Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis. Viruses 3:714-749.
74. Trocoli A, Djavaheri-Mergny M. 2011. The complex interplay between autophagy and NF-kappaB signaling pathways in cancer cells. Am. J. Cancer Res. 1:629-649.
75. Shelly S, Lukinova N, Bambina S, Berman A, Cherry S. 2009. Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus. Immunity 30:588-598.
76. Chen S, Rehman SK, Zhang W, Wen A, Yao L, Zhang J. 2010. Autophagy is a therapeutic target in anticancer drug resistance. Biochim. Biophys. Acta 1806:220-229.
77. Yang ZJ, Chee CE, Huang S, Sinicrope FA. 2011. The role of au tophagy in cancer: therapeutic implications. Mol. Cancer Ther. 10: 1533-1541.
78. Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E. 2011. Principles and current strategies for targeting autophagy for cancer treatment. Clin. Cancer Res. 17:654-666.
79. Rubinsztein DC, Gestwicki JE, Murphy LO, Klionsky DJ. 2007. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6:304-312.
80. Ross CA, Tabrizi SJ. 2011. Huntington's disease: from molecular pathogenesis to clinical treatment. Lancet Neurol. 10:83-98.
81. Sarkar S, Perlstein EO, Imarisio S, Pineau S, Cordenier A, Maglathlin RL, Webster JA, Lewis TA, O'Kane CJ, Schreiber SL, Rubinsztein DC. 2007. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3:331-338.